Global EditionASIA 中文雙語Fran?ais
    Business
    Home / Business / Q and A with CEO

    Innovation, sustainability driving growth

    China Daily | Updated: 2019-03-20 09:56
    Share
    Share - WeChat
    Leon Wang, executive vice-president of AstraZeneca International and president of AstraZeneca China. [Photo provided to China Daily]

    A1: Fast and stable economic development has been one of China's biggest achievements in the past decades.

    China's opening-up has offered AstraZeneca the chance to build long-term partnerships with academic, scientific and business communities in China to make more quality medicines and holistic disease management solutions available to patients. In 2017, we founded the Dizal joint-venture to promote the core competence of new drug development in China.

    A2: We are confident that China's economic growth rate will continue and be sustainable, as China is now focusing on the quality and sustainability of growth, rather than merely quantity. Fast developing technologies such as digital internet marketing pose growing challenges to the healthcare industry. We see challenges as opportunities. Astra-Zeneca China is leading the way in evolving from a simple drug supplier into an innovative medical enterprise that provides patients with comprehensive disease management solutions.

    A3: The Foreign Investment Law will provide a more solid guarantee for the legitimate rights of foreign companies on a legal level, creating a more open, fair and transparent investment environment in China. We believe that an optimized market as well as a positive and dynamic investment climate will maximize the initiative of innovation, attract and converge overseas resources, and further promote the cooperation of foreign and domestic companies, realizing mutual development.

    A4: China's macroeconomic growth has enabled Chinese companies to make significant progress in many aspects including public health. We see many opportunities for further collaboration with our partners in China to solve the most challenging problems in the healthcare industry.

    Among the most inspiring developments in digital health are new technologies that embrace the potential behind the internet of things and artificial intelligence, which is set to be one of the most significant advances in science in China and the United Kingdom.

    A5: The Chinese government has placed high importance on transforming government functions by streamlining administration, delegating power, enhancing oversight and providing better services. The pace of reform to cut red tape in China has been fast during the past five years. In healthcare, accelerating the approval process of new medicines is essential. We witnessed and supported the streamlining of administration. A good recent example is Tagrisso, an innovation discovered and developed in the UK that received approval in China in record time.

    |<< Previous 1 2 3 4 5 6 7 8 Next   >>|
    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    CLOSE
     
    中文字幕你懂的| 国产AV无码专区亚洲精品 | 国产成人一区二区三中文| 狠狠躁天天躁中文字幕无码| 久久午夜无码鲁丝片午夜精品| 国产成人无码精品久久久性色| 中文字幕无码乱人伦| 蜜臀AV无码国产精品色午夜麻豆 | 中文字幕1级在线| 中文字幕久精品免费视频| 久久久精品人妻无码专区不卡| 一本色道无码道DVD在线观看| 日本久久久久久中文字幕| 亚洲乱亚洲乱少妇无码| 波多野42部无码喷潮在线| 中出人妻中文字幕无码| 亚洲AV中文无码乱人伦在线视色| 中文字幕丰满乱孑伦无码专区 | 亚洲精品无码MV在线观看| 国产高清中文欧美| 日本免费中文字幕| 亚洲中文字幕无码爆乳AV| 惠民福利中文字幕人妻无码乱精品 | 日韩av无码久久精品免费| 亚洲综合无码精品一区二区三区 | 色综合久久中文综合网| 中文人妻无码一区二区三区| 无码专区6080yy国产电影| 无码视频在线播放一二三区| 无码国模国产在线无码精品国产自在久国产 | 国产亚洲精品无码专区| 99久久人妻无码精品系列| 亚洲精品无码不卡| 蜜臀精品无码AV在线播放| 无码精品人妻一区二区三区免费 | 18禁无遮拦无码国产在线播放| 日韩AV无码精品人妻系列| 国产精品无码专区| 久久无码人妻精品一区二区三区| 亚洲AV无码不卡在线观看下载| 蜜臀av无码人妻精品|